
The global Celiac Disease Testing market size is predicted to grow from US$ 894 million in 2025 to US$ 1353 million in 2031; it is expected to grow at a CAGR of 7.2% from 2025 to 2031.
Celiac disease is a digestive disorder that causes the body to have difficulty absorbing nutrients like fat, calcium, iron, and folate. It is an autoimmune disease in which gluten-containing foods cause damage to the small intestine lining.Celiac disease is diagnosed using a combination of serologic tests, small bowel biopsy, and a gluten-free diet response. Several serologic antibody tests can be used as initial tests. Antigliadin antibodies are no longer recommended for initial testing due to their low sensitivity and specificity.
The global celiac disease testing market refers to the market for diagnostic tests used to detect celiac disease, an autoimmune disorder where the body’s immune system reacts to gluten, a protein found in wheat, barley, and rye. Celiac disease can cause damage to the small intestine and lead to various symptoms, including gastrointestinal discomfort, malabsorption of nutrients, and other complications.
The market for celiac disease testing includes both laboratory-based tests and point-of-care (POC) tests. Laboratory-based tests involve analyzing blood samples for specific antibodies that are associated with celiac disease, such as anti-tissue transglutaminase (anti-tTG) antibodies, anti-endomysial antibodies (EMA), and anti-deamidated gliadin peptide (anti-DGP) antibodies. POC tests are designed to provide rapid and convenient results at the point of patient care, such as doctor’s offices or pharmacies.
The global celiac disease testing market is driven by several factors, including the increasing awareness and diagnosis of celiac disease, the growing demand for early and accurate detection, and the rising prevalence of the disease worldwide. According to the Celiac Disease Foundation, it is estimated that about 1% of the global population is affected by celiac disease.
In terms of geography, North America dominates the celiac disease testing market, followed by Europe. This can be attributed to the high awareness levels among healthcare professionals and patients, well-established healthcare infrastructure, and the presence of key market players in these regions. However, with increasing awareness and healthcare infrastructure development in emerging economies, such as China and India, the Asia-Pacific region is expected to witness substantial growth in the celiac disease testing market.
Key players in the global celiac disease testing market include diagnostic laboratories, healthcare providers, and companies specializing in diagnostic tests. These companies focus on developing innovative and accurate diagnostic tools for celiac disease, as well as providing comprehensive testing services. Additionally, research efforts are ongoing to discover new biomarkers and improve the efficiency and specificity of celiac disease testing.
Overall, the global celiac disease testing market is expected to experience significant growth in the coming years, driven by factors such as increasing awareness, improving diagnostic technologies, and rising global prevalence of celiac disease.
The “Celiac Disease Testing Industry Forecast” looks at past sales and reviews total world Celiac Disease Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Celiac Disease Testing sales for 2025 through 2031. With Celiac Disease Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Celiac Disease Testing industry.
This Insight Report provides a comprehensive analysis of the global Celiac Disease Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Celiac Disease Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Celiac Disease Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Celiac Disease Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Celiac Disease Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Celiac Disease Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Serologic Tests
Genetic Tests
Intestinal Biopsies
Others
Segmentation by Application:
Hospitals
Diagnostic Laboratories
Home Care
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
PRIMA Lab SA
Glutenostics
NanoRepro
Thermo Fisher Scientific
Targeted Genomics
YorkTest
Biohit Oyj
Labsystems Diagnostics Oy
Biomerica
Smartblood
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Celiac Disease Testing Market Size (2020-2031)
2.1.2 Celiac Disease Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Celiac Disease Testing by Country/Region (2020, 2024 & 2031)
2.2 Celiac Disease Testing Segment by Type
2.2.1 Serologic Tests
2.2.2 Genetic Tests
2.2.3 Intestinal Biopsies
2.2.4 Others
2.3 Celiac Disease Testing Market Size by Type
2.3.1 Celiac Disease Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Celiac Disease Testing Market Size Market Share by Type (2020-2025)
2.4 Celiac Disease Testing Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostic Laboratories
2.4.3 Home Care
2.4.4 Others
2.5 Celiac Disease Testing Market Size by Application
2.5.1 Celiac Disease Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Celiac Disease Testing Market Size Market Share by Application (2020-2025)
3 Celiac Disease Testing Market Size by Player
3.1 Celiac Disease Testing Market Size Market Share by Player
3.1.1 Global Celiac Disease Testing Revenue by Player (2020-2025)
3.1.2 Global Celiac Disease Testing Revenue Market Share by Player (2020-2025)
3.2 Global Celiac Disease Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Celiac Disease Testing by Region
4.1 Celiac Disease Testing Market Size by Region (2020-2025)
4.2 Global Celiac Disease Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Celiac Disease Testing Market Size Growth (2020-2025)
4.4 APAC Celiac Disease Testing Market Size Growth (2020-2025)
4.5 Europe Celiac Disease Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa Celiac Disease Testing Market Size Growth (2020-2025)
5 Americas
5.1 Americas Celiac Disease Testing Market Size by Country (2020-2025)
5.2 Americas Celiac Disease Testing Market Size by Type (2020-2025)
5.3 Americas Celiac Disease Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Celiac Disease Testing Market Size by Region (2020-2025)
6.2 APAC Celiac Disease Testing Market Size by Type (2020-2025)
6.3 APAC Celiac Disease Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Celiac Disease Testing Market Size by Country (2020-2025)
7.2 Europe Celiac Disease Testing Market Size by Type (2020-2025)
7.3 Europe Celiac Disease Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Celiac Disease Testing by Region (2020-2025)
8.2 Middle East & Africa Celiac Disease Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa Celiac Disease Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Celiac Disease Testing Market Forecast
10.1 Global Celiac Disease Testing Forecast by Region (2026-2031)
10.1.1 Global Celiac Disease Testing Forecast by Region (2026-2031)
10.1.2 Americas Celiac Disease Testing Forecast
10.1.3 APAC Celiac Disease Testing Forecast
10.1.4 Europe Celiac Disease Testing Forecast
10.1.5 Middle East & Africa Celiac Disease Testing Forecast
10.2 Americas Celiac Disease Testing Forecast by Country (2026-2031)
10.2.1 United States Market Celiac Disease Testing Forecast
10.2.2 Canada Market Celiac Disease Testing Forecast
10.2.3 Mexico Market Celiac Disease Testing Forecast
10.2.4 Brazil Market Celiac Disease Testing Forecast
10.3 APAC Celiac Disease Testing Forecast by Region (2026-2031)
10.3.1 China Celiac Disease Testing Market Forecast
10.3.2 Japan Market Celiac Disease Testing Forecast
10.3.3 Korea Market Celiac Disease Testing Forecast
10.3.4 Southeast Asia Market Celiac Disease Testing Forecast
10.3.5 India Market Celiac Disease Testing Forecast
10.3.6 Australia Market Celiac Disease Testing Forecast
10.4 Europe Celiac Disease Testing Forecast by Country (2026-2031)
10.4.1 Germany Market Celiac Disease Testing Forecast
10.4.2 France Market Celiac Disease Testing Forecast
10.4.3 UK Market Celiac Disease Testing Forecast
10.4.4 Italy Market Celiac Disease Testing Forecast
10.4.5 Russia Market Celiac Disease Testing Forecast
10.5 Middle East & Africa Celiac Disease Testing Forecast by Region (2026-2031)
10.5.1 Egypt Market Celiac Disease Testing Forecast
10.5.2 South Africa Market Celiac Disease Testing Forecast
10.5.3 Israel Market Celiac Disease Testing Forecast
10.5.4 Turkey Market Celiac Disease Testing Forecast
10.6 Global Celiac Disease Testing Forecast by Type (2026-2031)
10.7 Global Celiac Disease Testing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Celiac Disease Testing Forecast
11 Key Players Analysis
11.1 PRIMA Lab SA
11.1.1 PRIMA Lab SA Company Information
11.1.2 PRIMA Lab SA Celiac Disease Testing Product Offered
11.1.3 PRIMA Lab SA Celiac Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 PRIMA Lab SA Main Business Overview
11.1.5 PRIMA Lab SA Latest Developments
11.2 Glutenostics
11.2.1 Glutenostics Company Information
11.2.2 Glutenostics Celiac Disease Testing Product Offered
11.2.3 Glutenostics Celiac Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Glutenostics Main Business Overview
11.2.5 Glutenostics Latest Developments
11.3 NanoRepro
11.3.1 NanoRepro Company Information
11.3.2 NanoRepro Celiac Disease Testing Product Offered
11.3.3 NanoRepro Celiac Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 NanoRepro Main Business Overview
11.3.5 NanoRepro Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Celiac Disease Testing Product Offered
11.4.3 Thermo Fisher Scientific Celiac Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Targeted Genomics
11.5.1 Targeted Genomics Company Information
11.5.2 Targeted Genomics Celiac Disease Testing Product Offered
11.5.3 Targeted Genomics Celiac Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Targeted Genomics Main Business Overview
11.5.5 Targeted Genomics Latest Developments
11.6 YorkTest
11.6.1 YorkTest Company Information
11.6.2 YorkTest Celiac Disease Testing Product Offered
11.6.3 YorkTest Celiac Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 YorkTest Main Business Overview
11.6.5 YorkTest Latest Developments
11.7 Biohit Oyj
11.7.1 Biohit Oyj Company Information
11.7.2 Biohit Oyj Celiac Disease Testing Product Offered
11.7.3 Biohit Oyj Celiac Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Biohit Oyj Main Business Overview
11.7.5 Biohit Oyj Latest Developments
11.8 Labsystems Diagnostics Oy
11.8.1 Labsystems Diagnostics Oy Company Information
11.8.2 Labsystems Diagnostics Oy Celiac Disease Testing Product Offered
11.8.3 Labsystems Diagnostics Oy Celiac Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Labsystems Diagnostics Oy Main Business Overview
11.8.5 Labsystems Diagnostics Oy Latest Developments
11.9 Biomerica
11.9.1 Biomerica Company Information
11.9.2 Biomerica Celiac Disease Testing Product Offered
11.9.3 Biomerica Celiac Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Biomerica Main Business Overview
11.9.5 Biomerica Latest Developments
11.10 Smartblood
11.10.1 Smartblood Company Information
11.10.2 Smartblood Celiac Disease Testing Product Offered
11.10.3 Smartblood Celiac Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Smartblood Main Business Overview
11.10.5 Smartblood Latest Developments
12 Research Findings and Conclusion
Ěý
Ěý
*If Applicable.
